___

• Bilir A, Erguven M, Oktem G, Ozdemir A, Uslu A, Aktas E, Bonavinda B (2008). Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma. Int J Oncol 32: 829- 839.
• Bilir A, Erguven M, Yazihan N, Aktas E, Oktem G, Sabanci A (2010). Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y. J Neurooncol 100: 385-395.
• Chou TC (2006). Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58: 621-681.
• Desmarais JE, Looper KJ (2009). Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. J Clin Psychiatry 70: 1688-1697.
• DiPaola RS (2002). To arrest or not to G 2-M cell-cycle arrest. Clin Cancer Res 8: 3311-3314.
• Frick LR, Rapanelli M (2013). Antidepressants: Influence on cancer and immunity? Life Sci 92: 525-532.
• Hall MD, Okabe M, Shen DW, Liang XJ, Gottesman MM (2008). The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol 48: 495-535.
• Heim M, Scharifi M, Zisowsky J, Jaehde U, Voliotis D, Seeber S, Strumberg D (2005). The Raf kinase inhibitor BAY 43- 9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines. Anticancer Drugs 16: 129-136.
• Hsu SS, Huang CJ, Chen JS, Cheng HH, Chang HT, Jiann BP, Lin KL, Wang JL, Ho CM, Jan CR (2004). Effect of nortriptyline on intracellular Ca2+ handling and proliferation in human osteosarcoma cells. Basic Clin Pharmacol Toxicol 95: 124-130.
• Jeon SH, Kim SH, Kim Y, Kim YS, Lim Y, Lee YH, Shin SY (2011). The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells. Biochem Biophys Res Commun 413: 311-317.
• Kabolizadeh P, Engelmann BJ, Pullen N, Stewart JK, Ryan JJ, Farrell NP (2012). Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells. J Biol Inorg Chem 17: 123-132.
• Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, Paszat LF (2010). Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ 340: c693.
• Kinjo T, Kowalczyk P, Kowalczyk M, Walaszek Z, Nishimaki T, Slaga TJ, Hanausek M (2009). Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription. Mol Carcinog 48: 1123-1130.
• Koepsell H, Lips K, Volk C (2007). Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24: 1227-1251.
• Mao X, Hou T, Cao B, Wang W, Li Z, Chen S, Fei M, Hurren R, Gronda M, Wu D et al. (2011). The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence. Mol Pharmacol 79: 672-680.
• Mimura N, Hideshima T, Anderson KC (2015). Novel therapeutic strategies for multiple myeloma. Exp Hematol 43: 732-741.
• Pan CC, Shaw CF, Huang JK, Kuo CC, Kuo DH, Shieh P, Lu T, Chen WC, Ho CM, Jan CR (2010). Effect of nortriptyline on cytosolic Ca2+ regulation and viability in PC3 human prostate cancer cells. Drug Dev Res 71: 323-330.
• Rajkumar SV (2014). Multiple myeloma: 2014 update on diagnosis, risk-stratification and management. Am J Hematol 89: 998- 1009.
• Röllig C, Knop S, Bornhauser M (2015). Multiple myeloma. Lancet 385: 2197-2208.
• Ruetz S, Fabbro D, Zimmermann J, Meyer T, Gray N (2003). Chemical and biological profile of dual Cdk1 and Cdk2 inhibitors. Curr Med Chem Anticancer Agents 3: 1-14.
• Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A (1997). JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411: 77-82.
• Stepulak A, Rzeski W, Sifringer M, Brocke K, Gratopp A, Kupisz K, Turski L, Ikonomidou C (2008). Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells. Cancer Biol Ther 7: 1685-1693.
• Tsai CM, Chen JT, Stewart DJ, Chiu CH, Lai CL, Hsiao SY, Chen YM, Chang KT (2011). Antagonism between gefitinib and cisplatin in non-small cell lung cancer cells: why randomized trials failed? J Thorac Oncol 6: 559-568.
• Tsakalozou E, Eckman AM, Bae Y (2012). Combination effects of docetaxel and doxorubicin in hormone-refractory prostate cancer cells. Biochem Res Int 10: 832059.
• Yeragani VK, Roose S, Mallavarapu M, Radhakrishna RK, Pesce V (2002). Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. Neuropsychobiology 46: 125-135.
• Yuan SY, Cheng CL, Ho HC, Wang SS, Chiu KY, Su CK, Ou YC, Lin CC (2015). Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo. Eur J Pharmacol 761: 309-320.
• Zhang N, Dai L, Qi Y, Di W, Xia P (2013). Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: role of autophagy. Int J Oncol 42: 2053-2059.
• Zhang Z, Du X, Zhao C, Cao B, Zhao Y, Mao X (2013). The antidepressant amitriptyline shows potent therapeutic activity against multiple myeloma. Anticancer Drugs 24: 792-798.